RU
Address
220006, Minsk, Leningradskaya Str. 6, office 2
Tel.: +375 17 363-88-92
E-mail: medjournal@bsmu.by

Врожденная цитомегаловирусная инфекция на современном этапе

Т.А. Артемчик УО «Белорусский государственный медицинский университет»
2012 №3 | Оригинальные научные публикации
Аннотация
Список литературы
Скачать полнотекстовую статью
В статье представлены эпидемиологические, клинические особенности врожденной цитомегаловирусной инфекции, тактика диагностики и лечения.
Ключевые слова:
врожденная цитомегаловирусная инфекция, дети, диагностика
Сongenital cytomegalovirus infection

In the article was presented review of epidemiological, clinical features, diagnostics, treatment of congenital cytomegalovirus infection.

Keywords
congenital cytomegalovirus infection, children, diagnostics
  • 1. Володин, Н. Н. Показатели смертности и рождаемости в Российской Федерации / Н. Н. Володин // Педиатрия: журнал им. Г. Н. Сперанского.– 2006. – №1. – С. 5–8.
  • 2. Серопозитивные к ЦМВ женщины фертильного возраста – состояние проблемы и пути решения / Т. А. Артемчик [и др.] // Медицинская панорама.–2010. – №6. – с. 58–60.
  • 3. Володин, Н. Н. Показатели смертности и рождаемости в Российской Федерации / Н. Н. Володин // Педиатрия: журнал им. Г. Н. Сперанского. – 2006. – №1. – С. 5–8.
  • 4. Цинзерлинг, В. А. Перинатальные инфекции. Вопросы патогенеза, морфологической диагностики и клинико-морфологических сопоставлений: практическое руководство / В. А. Цинзерлинг., В.Ф. Мельникова. – СПб.: Элби, 2002. – 352 с.
  • 5. Boeckh, M. How we treat cytomegalovirus in hematopoietic cell transplant recipients / M. Boeckh, P. Ljungman // Blood. – 2009. – Vol.113. – P. 5711–5719.
  • 6. Cheeran, M. C Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention / M. C Cheeran, J. R. Lokensgard, M. R. Schleiss// Clin Microbiol Rev. 2009. – №22. – P. 99–126.
  • 7. Clinical predictive value of real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples / T. Goegebuer [ et al.]// J. Clin. Microbiol. – 2009. – Vol. 47. – P. 660–665.
  • 8. Comparison of DNA extraction methods from small samples of newborn screening cards suitable for retrospective perinatal viral research/ G. L. McMichael [et al.]// J. Biomol. Tech. – 2011. – Vol.22. – P.5–9.
  • 9. Comparison of infectious complications during induction / consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantation / C. Orasch[ et al.]// Bone Marrow Transplantation. – 2009. – Vol.12. – P.407–411.
  • 10. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome / R. F. Pass [et al.] // J. Clin. Virol. – 2006. – Vol. 35. – P.216–220. [PubMed]
  • 11. Cytomegalovirus infection in pregnancy: review of the literature/ S.Bonalumi [ et al.]// J. Prenat. Med. – 2011. – Vol.5. – P.1–8.
  • 12. Cytomegalovirus in the perilymphatic fluid / P. W. Bauer[ et al.] //Laryngoscope. – 2005. – Vol.115. – P.223-225.
  • 13. Cytomegalovirus viruria and DNAemia in healthy seropositive women/ N.Arora [et al.]// J. Infect. Dis. – 2010. – Vol.202. – P. 1800–1803.
  • 14. Do pathogen exposure and innate immunity cause brain diseases? / A.R. Simard, S. Rivest // Neurol. Res. – 2005. – Vol.27. – P.717–725. [PubMed]
  • 15. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection/ S.B. Boppana [et al.] //JAMA. – 2010. – Vol. 303. – P.1375–1382.
  • 16. Emerging infectious disease outbreaks: old lessons and new challenges for obstetrician-gynecologists/ G. Hahn [et al.] // Am. J. Obstet. Gynecol.–2006. – Vol.194. – P.1546–1555.
  • 17. Ganciclovir population pharmacokinetic in neonates following intravenous administration of ganciclovir and oral administration of liquid valganciclovir formulation / EP Agosta [et al.]// Clin Pharmacol Ther. – 2007. – Vol.81. – P. 867–872.
  • 18. Guidelines on CMV congenital infection / O. Coll [et al.] // J Perinat Med. 2009. – Vol. 37. – P.433–445.
  • 19. Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity/ S. A. Ross [et al.] // J. Pediatr. – 2006. – Vol.148. – P. 332–336. [PubMed]
  • 20. Hearing loss in children with congenital cytomegalovirus infection in relation to the maternal trimester in which the maternal primary infection occurred / I. Foulon [et al.] // J.Pediatr. – 2008. – Vol. 122. – Р. 1123–1127.
  • 21. Kenneson, A. Review and meta-analysis of the epidemiology of congenital cytomegalovirus infection/ A. Kenneson, M.J. Cannon // Rev Med Virol. – 2007. – Vol 17. – P.253–276.
  • 22. Kotton, C. N. Management of cytomegalovirus infection in solid organ transplantation / C. N. Kotton // Nat.Rev. Nephrol. – 2010. – Vol.6. – P.711– 712.
  • 23. Marshal, B. C. Antivirals for cytomegalovirus infection in neonates and infants / B. C. Marshal, W.C. Koch //Pediatr.Drugs. – 2009. – Vol. 11. – P. 309–321.
  • 24. Milewska-Bobula, B. Congenital cytomegaly-advances in diagnosis and therapy/ B. Milewska-Bobula, B. Lipka // Przegl Epidemiol.– 2009. – Vol.63. – P.79–83.
  • 25. Morton, C. C. Newborn hearing screening-a silent revolution / C. C. Morton, W. E. Nance // N Engl J Med. – 2006. - Vol 354. – P. 2151-2164.
  • 26. Nelson Textbook of Pediatrics, 18th ed.2007, ch 252.
  • 27. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system/ S. E. Oliver[et al.] //J Clin Virol. – 2009. – Vol. 46. – P.22–26.
  • 28. New advances in the diagnosis of congenital cytomegalovirus infection/T. Lazzarotto [et al.] // J Clin Virol. !2008. - Vol. 41. – P. 192–197.
  • 29. Newborn hearing screening and detection of congenital cytomegalovirus infection /E K Stehe [et al.] // JPediatr. ! 2008. – Vol. 121. – Р. 970–975.
  • 30. Obstetrician / gynecologists' knowledge, attitudes, and practices regarding prevention of infections in pregnancy/ D.S. Ross[ et al.]// J. Womens Health (Larchmt). – 2009. – Vol.18. – P. 1187–1193.
  • 31. Overview of the diagnosis of cytomegalovirus infection/ S.A. Ross[ et al.]// Infect Disord Drug Targets). – 2011. – Vol.11. – P.466–474.
  • 32. Pharmacokinetic profile of valganciclovir in pediatric transplant recipients/ E. Launay [et al.] // Pediatr. Infect. Dis. J. – 2012. – Vol. 31. – P.405–407.
  • 33. Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease / R. La Torre [et al.] // Clin. Infect. Dis.–2006. – Vol.43. – P.994–1000.
  • 34. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns/ S. B. Boppana [et al.] // N. Engl. J. Med. – 2011. – Vol. 364. – P.73–77.
  • 35. Schulzke, S Valganciclovir for treatment of congenital cytomegalovirus infection / S. Schulzke, C. Buhrer / Eur J Pediatr. – 2006. – Vol. 165. – Р. 575– 576.
  • 36. Severe morbidity and mortality with breast milk associated cytomegalovirus infection / M Hamele [et al.] //Pediatr Infect Dis J. – 2010. – Vol. 29. – P. 84–86.
  • 37. Szenborn, L. Significance of diagnostics and treatment in preventing congenital infections with Toxoplasma gondii (Tg), cytomegalovirus (CMV) and parvowirus B19 (PVB19) / L. Szenborn// Przegl Lek. – 2010. – Vol.61. – P.54–57.
  • 38. The Centers for Disease Control and Prevention Web site. About CMV. Available at: www.cdc.gov/cmv/facts.htm . Accessed March 29, 2006.
  • 39. The epidemiology and prevention of congenital cytomegalovirus infection and disease: activities of the Centers for Disease Control and Prevention Workgroup / S. A. Ross [et al.] // J. Womens Health (Larchmt.). – 2006. – Vol.15. – P. 224–229. [PubMed]
  • 40. Valganciclovir for Congenital Cmv Infection: A Pilot Study on Plasma Concentration in Newborns and Infants / L Galli [et al.]// Pediatr Infect Dis J. – 2007. – Vol.26. – P.451–453.
  • 41. Yinon, Y. Screening, diagnosis, and management of cytomegalovirus infection in pregnancy /Y. Yinon, D. Farine, M.H. Yudin // Obstet. Gynecol. Surv. – 2010. – Vol.65. – P.736–743.